Western pharmaceutical companies have invested tens of billions of dollars in Chinese biotechnology companies and licensing agreements to bolster their drug development pipelines

From the articleTrump administration proposes new curbs on China biotech dealsAlso in US Proposes Curbs on Investment in Chinese Biotech Firms